This x-ray of the pelvis shows an electronic nerve-stimulating device in the right iliac fossa. Over 10 months, complete continence was achieved by approximately half of implanted patients. Real-world ...

April 26, 2010 (Barcelona, Spain) — Chronic sacral neuromodulation (SNM) provides effective long-term control of refractory painful bladder syndrome/interstitial cystitis (PBS/IC), according to ...

WASHINGTON, D.C.—Sacral neuromodulation with InterStim Therapy is safe and well tolerated as a treatment for patients with overactive bladder and those with urinary retention, French investigators ...

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics Modulation Technologies, Inc. (NASDAQ:AXNX), a medical technology company that has developed and is commercializing a novel implantable rechargeable sacral ...

Sacral neuromodulation (SNM) is effective -- at least in the short term -- for patients with a type of urinary tract dysfunction, according to Swiss investigators. In a sham-controlled, double-blind ...

SAN JOSE, Calif., June 18, 2025 /PRNewswire/ -- Neuspera ® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food ...

A 41-year-old nurse from Severance shopping for a solution to her overactive bladder symptoms found a way to regain full control thanks to an innovative procedure. Sarah Avrech said goodbye to a life ...

A 26-year-old female who had been suffering from overactive painful bladder for the last 12 years receives advanced sacral neuromodulation to treat overactive painful bladder Post Graduate Institute ...

Boston Scientific kicked off one of the most important healthcare conferences of the year (J.P. Morgan) with a $3.7 billion deal to bolster its urology portfolio. The Marlborough, MA-based company has ...

SAN JOSE, Calif., June 18, 2025 /PRNewswire/ -- Neuspera® Medical, Inc., the leading developer of integrated technologies powering the future of neuromodulation, today announced that the U.S. Food and ...